G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,332,084 | -13.3% | 2,543,006 | -6.6% | 0.00% | 0.0% |
| Q1 2023 | $7,300,057 | +47753.5% | 2,723,902 | -3.0% | 0.00% | -60.0% |
| Q4 2022 | $15,255 | -100.0% | 2,809,444 | -4.3% | 0.01% | -63.0% |
| Q3 2022 | $36,662,000 | +221.5% | 2,935,332 | +27.2% | 0.03% | +237.5% |
| Q2 2022 | $11,404,000 | -35.1% | 2,308,555 | -0.1% | 0.01% | -20.0% |
| Q1 2022 | $17,565,000 | -24.1% | 2,311,138 | +1.9% | 0.01% | -23.1% |
| Q4 2021 | $23,157,000 | -0.7% | 2,268,074 | +30.5% | 0.01% | -7.1% |
| Q3 2021 | $23,327,000 | +16.2% | 1,738,211 | +90.0% | 0.01% | +7.7% |
| Q2 2021 | $20,072,000 | – | 914,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |